Does Shilajit Raise Your Hormones? What the Research on the Hormone-Making Enzymes Actually Shows

What the research does show is something more specific, and frankly more interesting. Fulvic acid, shilajit's signature compound, appears to interact with the enzymes your body uses to make its own steroid hormones. That mechanism is entirely different from flooding the system with an external hormone the way a patch or a pill does.

Why does "does it raise hormones" get asked so often?

Any woman who has looked into a fulvic-acid supplement during menopause has likely run into a version of this fear. The word "hormone" gets used loosely online, sometimes to mean genuine endocrine science and sometimes to mean marketing shorthand for "makes you feel younger." That vagueness is exactly what makes a real, honest answer worth having.

There are two structurally different ways a compound can touch your hormone system. The first is direct, the exogenous route, where the compound itself acts as a hormone once it is in your bloodstream, the way estradiol in a patch does. The second is indirect, the enzymatic route, where a compound supports or interferes with the machinery that manufactures, converts, or clears hormones your own glands are already trying to produce. Shilajit's documented mechanism is the second kind, never the first.

The negative-feedback problem with the first route

Exogenous hormone replacement works, and it works precisely because it delivers hormone directly. But that directness has a well-known tradeoff.

The body's hormone axes run on negative feedback. When the brain senses enough hormone circulating, it dials back its own signal to produce more. That is why exogenous testosterone, for instance, is known to suppress a man's natural testicular production over time. It is not a flaw in the drug. It is how feedback loops work everywhere in biology.

What does the enzyme-level research on shilajit actually show?

This is where the science gets specific, and where the honest limits matter as much as the finding itself.

A 2024 study published on shilajit's steroidogenic activity used a mouse model of chemotherapy-induced testicular damage. Researchers found that shilajit "enhances testosterone biosynthesis by activating enzymes like 3-beta-HSD and 17-beta-HSD" while helping restore germ-cell function damaged by the chemotherapy agent. Those two enzymes are not obscure. 3-beta-HSD in particular sits at a genuine fork in steroid hormone production, it is the enzyme that converts a shared precursor molecule into progesterone, one step upstream of where the pathway branches toward either the androgen or estrogen lines.

That is the only steroidogenic-enzyme evidence currently in the shilajit literature, and it comes with three hard limits worth naming rather than glossing over:

• It was conducted in mice, not humans.
• The animals were male, and the tissue studied was testicular, not ovarian or adrenal.
• The model was a toxicity-rescue design, meaning it measured recovery from chemical damage, not a healthy baseline response in an otherwise normal animal.
• The outcome measured was testosterone biosynthesis, not estrogen or progesterone output directly.
• No dose-response curve was established, so there is no data on how much shilajit produces how much enzyme activation.

None of that means the finding is meaningless. It means the honest sentence is "shilajit has been shown to activate specific hormone-synthesizing enzymes in one animal model," not "shilajit boosts your hormones," and the difference between those two sentences is the entire point of this article.

A second enzyme system, the stress-hormone axis

A separate line of research looked at a different axis entirely, the HPA axis, which governs cortisol, the adrenal stress hormone. In a rat model of chronic-fatigue-like stress, shilajit reversed a stress-induced drop in corticosterone (the rodent equivalent of cortisol) and prevented the accompanying loss of adrenal gland weight, alongside preserved mitochondrial enzyme activity. The study authors framed this as evidence of HPA axis modulation.

That finding matters here for one reason. It is a second, independent line of evidence that fulvic acid's mechanism runs through regulating an existing hormone-producing system rather than substituting for it. It is not a female-hormone finding, and it should never be stretched to imply one. Corticosterone is a stress hormone, not a sex hormone, and this is a rat model, not a human trial.

Is there any human data on shilajit and hormone levels directly?

There is one, and it deserves to be presented with its limitations stated up front rather than buried in a footnote.

A 2025 human study measured hormone levels in participants before and after a period of shilajit use, finding higher estrogen and progesterone in the women in the study, and higher testosterone, LH, and FSH in the men, compared with their own pre-treatment baseline. It is a genuinely interesting data point and the only direct human hormone-panel evidence on shilajit that exists.

It is also, by design, a weak-tier trial. There was no placebo comparison group, so there is no way to separate a true treatment effect from normal week-to-week hormone fluctuation, seasonal variation, or a simple regression toward the mean. The sample was 40 people total, split across both sexes. No peer-reviewed PMID-indexed publication exists for it. A single before-and-after study without a control arm can suggest a hypothesis. It cannot confirm one, and this article is not going to pretend otherwise.

How this compares to what a hormone drug actually does

Where does the estrogen-safety question fit into all of this?

Many women researching shilajit during menopause are not just asking whether it raises hormones. They are asking whether it is safe for someone who has been told to avoid estrogen exposure for medical reasons, often after a breast cancer history or a strong family risk.

That is a distinct scientific question from the enzyme question above, and it has its own separate evidence base. In-vitro research using MCF-7 breast cancer cell lines, cells that grow specifically in response to estrogen, has tested shilajit-derived compounds directly against those cells alongside normal, non-cancerous cell lines. The compounds triggered programmed cell death in the cancer cell line while relatively sparing the normal cells, the opposite pattern of what actual estrogen exposure produces in that same cell model. That is laboratory, cell-level evidence, not a human clinical trial, and it answers a cancer-cell-behavior question, not a whole-body hormone-level question.

Two separate questions are easy to blur together, and worth keeping apart:

• Does shilajit raise circulating hormone levels the way a drug does? The enzyme and small human-study evidence above says probably not in that direct sense.
• Does shilajit behave like estrogen inside estrogen-sensitive cancer cells? The MCF-7 lab evidence above says no, but it is cell-level evidence, not a clinical safety trial.
• Has either question been settled by a large, controlled human trial? No, and this article says so plainly rather than implying otherwise.

Anyone navigating a personal or family history relevant to either question should bring both, by name, to their own doctor rather than assuming one answer settles the other.

What is the honest, whole-picture answer?

Put together, here is what can and cannot be said with a straight face:

• Shilajit contains no hormones and has never been shown to act as one.
• Animal research shows fulvic acid can activate specific steroid-synthesizing enzymes, in a male, testicular, toxicity-recovery model.
• A separate rat study shows fulvic acid modulates the stress-hormone (HPA) axis, a related but distinct system.
• One small, uncontrolled human study found higher hormone levels after shilajit use, a real but weak signal that needs a properly controlled trial to confirm.
• Cell-line research suggests shilajit's compounds do not behave like estrogen in cancer-cell growth models, a separate safety question worth its own conversation with a doctor.
• No trial has measured shilajit against a standard clinical hormone panel with a placebo arm, so the strongest honest claim is mechanism, not outcome.
• Nothing in the current research supports treating shilajit as a substitute for a prescribed hormone therapy.

Optimum Shilajit

That is a mechanism story about supporting the body's own hormone-making machinery, told honestly with every gap disclosed, not a marketing shortcut dressed up as settled science. Fulvic acid's broader, better-established role is as a mineral carrier, delivering magnesium, zinc, and dozens of trace elements that the enzymes described above and hundreds of others throughout the body depend on to function at all. If you want to support that whole-body mineral and enzyme foundation while staying clear-eyed about what is and is not proven, Optimum Shilajit is Altai mountain shilajit, third-party tested, in a simple two-tablet daily dose.

See Optimum Shilajit